[Federal Register Volume 81, Number 234 (Tuesday, December 6, 2016)]
[Page 87939]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-29175]



Centers for Disease Control and Prevention

Office for State, Tribal, Local and Territorial Support (OSTLTS)

    In accordance with Presidential Executive Order No. 13175, November 
6, 2000, and the Presidential Memorandum of November 5, 2009, and 
September 23, 2004, Consultation and Coordination with Indian Tribal 
Governments, CDC/Agency for Toxic Substances and Disease Registry 
(ATSDR), announces the following meetings and Tribal Consultation 
    Name: Tribal Caucus, CDC/ATSDR Tribal Advisory Committee (TAC) 
Meeting and 16th Biannual Tribal Consultation Session
    Times and Dates:
    8:00 a.m.-5:00 p.m., EST, February 14, 2017 (Tribal Caucus)
    8:00 a.m.-5:00 p.m., EST, February 15, 2017 (TAC Meeting and 16th 
Biannual Tribal Consultation Session)
    Place: The Tribal Caucus, TAC Meeting and Tribal Consultation 
Session will be held at CDC, Global Communications Center, Building 19, 
Auditorium B3, 1600 Clifton Road NE., Atlanta, Georgia 30329.
    Status: The meetings are being hosted by CDC/ATSDR in-person only 
and are open to the public. Attendees must pre-register for the event 
by Friday, January 13, 2017, at the following link: http://www.cdc.gov/tribal/meetings.html.
    Purpose: The purpose of these recurring meetings is to advance CDC 
and ATSDR support for and collaboration with American Indian and Alaska 
Native (AI/AN) tribes, and to improve the health of AI/AN tribes by 
pursuing goals that include assisting in eliminating the health 
disparities faced by AI/AN tribes; ensuring that access to critical 
health and human services and public health services is maximized to 
advance or enhance the social, physical, and economic status of AI/ANs; 
and promoting health equity for all Indian people and communities. To 
advance these goals, CDC and ATSDR conducts government-to-government 
consultations with elected tribal officials or their authorized 
representatives. Consultation is an enhanced form of communication that 
emphasizes trust, respect, and shared responsibility. It is an open and 
free exchange of information and opinion among parties that leads to 
mutual understanding and comprehension.
    Matters for Discussion: The TAC Meeting and Biannual Tribal 
Consultation Session will provide opportunities for tribal leaders to 
speak openly about the public health issues affecting their tribes. 
These meetings will include, but are not limited to, discussions about 
advancing CDC's tribal budget consultation process, connecting cultural 
and traditional practices to evidence-based interventions, and 
expanding disease prevention efforts throughout Indian country.
    Tribes will also have an opportunity to present testimony about 
tribal health issues. All Tribal leaders are encouraged to submit 
written testimony by 5:00 p.m., EST, Friday, January 13, 2017, to LCDR 
Jessica Damon, Public Health Advisor for the Tribal Support Unit, 
OSTLTS, via mail to 4770 Buford Highway NE., MS E-70, Atlanta, Georgia, 
30341-3717 or email to [email protected].
    Based on the number of tribal leaders giving testimony and the time 
available, it may be necessary to limit the time for each presenter.
    The agenda is subject to change as priorities dictate.
    Information about the TAC, CDC/ATSDR's Tribal Consultation Policy, 
and previous meetings can be found at http://www.cdc.gov/tribal.
    Contact person for more information: LCDR Jessica Damon, Public 
Health Advisor, CDC/OSTLTS, 4770 Buford Highway NE., MS E-70, Atlanta, 
Georgia 30341-3717; email: [email protected] or telephone (404) 
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-29175 Filed 12-5-16; 8:45 am]